Screening for critical drug targets known as G-protein-coupled receptors (GPCRs) is now possible without the need to extract these proteins from their native cells. Extraction requires the use of stabilizing lipids, which ...
Biochemistry
Jul 3, 2013
0
0
Researchers at RMIT University are developing new generation nano-sized drug delivery technology.
Bio & Medicine
Jul 2, 2013
0
0
Muthu Alagappan arrived at Stanford University with his heart set on attending medical school, and he still hopes to become a doctor someday.
Mathematics
Jun 20, 2013
0
0
A pioneering imaging technique to track the effects of next-generation nanomedicines on patients has been harnessed by a University of Strathclyde academic.
Bio & Medicine
May 29, 2013
0
0
(Phys.org) —The protein tumor necrosis factor-alpha (TNF-alpha) is a powerful weapon in the arsenal to control cancer. Unfortunately, as is the case with many potent cancer therapies, the use of TNF-alpha as an anti-cancer ...
Bio & Medicine
May 8, 2013
0
0
Apoptosis is a programmed death mechanism that eliminates unwanted or injured cells from the body. Defects in apoptotic regulation can lead to serious physiological problems such as tissue damage or uncontrolled cancerous ...
Biochemistry
May 8, 2013
0
0
A British scientist convicted of scientific fraud last month for falsifying research data has been sentenced to three months jail. Steven Eaton is the first person to serve time under the UK's Good Laboratory Practice Regulations, ...
Other
Apr 19, 2013
1
0
Combined research efforts by scientists involved in the Gulf of Maine Toxicity (GOMTOX) project, funded by NOAA's Ecology and Oceanography of Harmful Algal Blooms (ECOHAB) program, and administered by the National Centers ...
Environment
Apr 10, 2013
1
0
(Phys.org) —Every available cancer drug is susceptible to resistance, according to Mansoor Amiji, Distinguished Professor and chair of the Department of Pharmaceutical Sciences. Tumors grow more quickly than blood vessels, ...
Bio & Medicine
Mar 19, 2013
1
0
Modern medicine is largely based on treating patients with "small-molecule" drugs, which include pain relievers like aspirin and antibiotics such as penicillin.
Bio & Medicine
Mar 11, 2013
0
0
